PROVIDENCE, R.I. and PARIS--(BUSINESS WIRE)--Nabsys, Inc., a life sciences company pioneering semiconductor-based tools for human genomic analysis in oncology, and Ariana Pharmaceuticals SA, a developer of innovative clinical data analysis and diagnostic solutions for the healthcare sector, today announced a collaboration that aims to identify sets of DNA structural variants linked to prostate and breast cancers and to the clinical outcome of patients with these diseases through the analysis of